Literature DB >> 19346298

Imaging schistosomes in vivo.

Greice Krautz-Peterson1, David Ndegwa, Kristine Vasquez, Houari Korideck, Jun Zhang, Jeffrey D Peterson, Patrick J Skelly.   

Abstract

Schistosomes are intravascular, parasitic helminths that cause a chronic, often debilitating disease afflicting over 200 million people in over 70 countries. Here we describe novel imaging methods that, for the first time, permit visualization of live schistosomes within their living hosts. The technology centers on fluorescent agent uptake and activation in the parasite's gut, and subsequent detection and signal quantitation using fluorescence molecular tomography (FMT). There is a strong positive correlation between the signal detected and parasite number. Schistosoma mansoni parasites of both sexes recovered from infected experimental animals exhibit vivid fluorescence throughout their intestines. Likewise, the remaining important human schistosome parasites, S. japonicum and S. hematobium, also exhibit gut fluorescence when recovered from infected animals. Imaging has been used to efficiently document the decline in parasite numbers in infected mice treated with the antischistosome drug praziquantel. This technology will provide a unique opportunity both to help rapidly identify much-needed, novel antischistosome therapies and to gain direct visual insight into the intravascular lives of the major schistosome parasites of humans.

Entities:  

Mesh:

Year:  2009        PMID: 19346298      PMCID: PMC2717771          DOI: 10.1096/fj.08-127738

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  58 in total

Review 1.  Proteinases and associated genes of parasitic helminths.

Authors:  J Tort; P J Brindley; D Knox; K H Wolfe; J P Dalton
Journal:  Adv Parasitol       Date:  1999       Impact factor: 3.870

Review 2.  Does the neuropeptide somatostatin have therapeutic potential against schistosomiasis?

Authors:  Shyama Chatterjee; Amadou Mbaye; Joris G De Man; Eric A E Van Marck
Journal:  Trends Parasitol       Date:  2002-07

Review 3.  In vivo imaging enters parasitology.

Authors:  Volker Heussler; Christian Doerig
Journal:  Trends Parasitol       Date:  2006-03-20

4.  Transduction of Schistosoma mansoni by vesicular stomatitis virus glycoprotein-pseudotyped Moloney murine leukemia retrovirus.

Authors:  Kristine J Kines; Victoria H Mann; Maria E Morales; Bryan D Shelby; Bernd H Kalinna; Geoffrey N Gobert; Sharon R Chirgwin; Paul J Brindley
Journal:  Exp Parasitol       Date:  2006-03-10       Impact factor: 2.011

5.  Artesunate and praziquantel for the treatment of Schistosoma haematobium infections: a double-blind, randomized, placebo-controlled study.

Authors:  S Borrmann; N Szlezák; J F Faucher; P B Matsiegui; R Neubauer; R K Binder; B Lell; P G Kremsner
Journal:  J Infect Dis       Date:  2001-10-29       Impact factor: 5.226

6.  Toxoplasma gondii: inconsistent dissemination patterns following oral infection in mice.

Authors:  Jon P Boyle; Jeroen P J Saeij; John C Boothroyd
Journal:  Exp Parasitol       Date:  2007-01-25       Impact factor: 2.011

7.  Mass spectrometric detection of urinary oligosaccharides as markers of Schistosoma mansoni infection.

Authors:  Marjolein L M Robijn; Joost Planken; Dieuwke Kornelis; Cornelis H Hokke; André M Deelder
Journal:  Trans R Soc Trop Med Hyg       Date:  2007-11-09       Impact factor: 2.184

8.  Activity of 9-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]adenine against Schistosomiasis mansoni in mice.

Authors:  Sanaa Botros; Samia William; Olfat Hammam; Zdenĕk Zídek; Antonín Holý
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

9.  Schistosoma mansoni miracidia transformed by particle bombardment infect Biomphalaria glabrata snails and develop into transgenic sporocysts.

Authors:  Oliver Heyers; Anna K Walduck; Paul J Brindley; Wilfrid Bleiss; Richard Lucius; Tomislav Dorbic; Burghardt Wittig; Bernd H Kalinna
Journal:  Exp Parasitol       Date:  2003-10       Impact factor: 2.011

Review 10.  The unacknowledged impact of chronic schistosomiasis.

Authors:  Charles H King; Madeline Dangerfield-Cha
Journal:  Chronic Illn       Date:  2008-03
View more
  8 in total

Review 1.  Noninvasive biophotonic imaging for studies of infectious disease.

Authors:  Nuria Andreu; Andrea Zelmer; Siouxsie Wiles
Journal:  FEMS Microbiol Rev       Date:  2010-10-19       Impact factor: 16.408

Review 2.  Schistosomiasis in the People's Republic of China: the era of the Three Gorges Dam.

Authors:  Donald P McManus; Darren J Gray; Yuesheng Li; Zheng Feng; Gail M Williams; Donald Stewart; Jose Rey-Ladino; Allen G Ross
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

3.  In vivo imaging of schistosomes to assess disease burden using positron emission tomography (PET).

Authors:  Nicolas Salem; Jason D Balkman; Jing Wang; David L Wilson; Zhenghong Lee; Christopher L King; James P Basilion
Journal:  PLoS Negl Trop Dis       Date:  2010-09-21

Review 4.  Immune effector mechanisms against schistosomiasis: looking for a chink in the parasite's armour.

Authors:  R Alan Wilson; Patricia S Coulson
Journal:  Trends Parasitol       Date:  2009-08-28

Review 5.  The use of imaging to detect schistosomes and diagnose schistosomiasis.

Authors:  P J Skelly
Journal:  Parasite Immunol       Date:  2013 Sep-Oct       Impact factor: 2.280

6.  Identification and characterization of a Mef2 transcriptional activator in schistosome parasites.

Authors:  John N Milligan; Emmitt R Jolly
Journal:  PLoS Negl Trop Dis       Date:  2012-01-03

7.  Tracing of the Bile-chemotactic migration of juvenile Clonorchis sinensis in rabbits by PET-CT.

Authors:  Tae Im Kim; Won Gi Yoo; Byung Kook Kwak; Ju-Won Seok; Sung-Jong Hong
Journal:  PLoS Negl Trop Dis       Date:  2011-12-13

8.  Early Detection of Acute Drug-Induced Liver Injury in Mice by Noninvasive Near-Infrared Fluorescence Imaging.

Authors:  Kristine O Vasquez; Jeffrey D Peterson
Journal:  J Pharmacol Exp Ther       Date:  2017-01-23       Impact factor: 4.030

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.